GlycoMimetics (GLYC)
(Delayed Data from NSDQ)
$0.16 USD
0.00 (0.00%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $0.16 0.00 (-2.74%) 6:08 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for GlycoMimetics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -36.90 | -46.69 | -63.43 | -51.03 | -57.89 |
Depreciation/Amortization & Depletion | 0.15 | 0.21 | 0.26 | 0.27 | 0.28 |
Net Change from Assets/Liabilities | -2.56 | -4.66 | -1.17 | 3.93 | -1.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.43 | 4.69 | 6.84 | 7.58 | 6.84 |
Net Cash From Operating Activities | -34.88 | -46.46 | -57.49 | -39.24 | -51.98 |
Property & Equipment | -0.02 | -0.08 | -0.01 | -0.07 | -0.14 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.02 | -0.08 | -0.01 | -0.07 | -0.14 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 28.82 | 4.16 | 10.72 | 18.14 | 0.41 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 28.82 | 4.16 | 10.72 | 18.14 | 0.41 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -6.08 | -42.38 | -46.78 | -21.17 | -51.72 |
Cash at Beginning of Period | 47.87 | 90.25 | 137.04 | 158.20 | 209.92 |
Cash at End of Period | 41.79 | 47.87 | 90.25 | 137.04 | 158.20 |
Diluted Net EPS | -0.58 | -0.89 | -1.23 | -1.12 | -1.34 |
Fiscal Year End for GlycoMimetics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.83 | -10.74 | -36.90 | -27.82 | -18.62 |
Depreciation/Amortization & Depletion | 0.03 | 0.01 | 0.15 | 0.13 | 0.09 |
Net Change from Assets/Liabilities | -1.42 | -1.18 | -2.56 | -2.86 | -2.22 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.82 | 1.40 | 4.43 | 3.28 | 2.17 |
Net Cash From Operating Activities | -19.40 | -10.51 | -34.88 | -27.26 | -18.58 |
Property & Equipment | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.01 | 0.00 | 28.82 | 28.82 | 28.76 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.01 | 0.00 | 28.82 | 28.82 | 28.76 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -19.41 | -10.51 | -6.08 | 1.54 | 10.17 |
Cash at Beginning of Period | 41.79 | 41.79 | 47.87 | 47.87 | 47.87 |
Cash at End of Period | 22.39 | 31.28 | 41.79 | 49.41 | 58.04 |
Diluted Net EPS | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 |